Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2025.03.31
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2025.03.31
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE
2025.03.28
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
2025.03.14
DATE OF BOARD MEETING
2025.02.26
VOLUNTARY ANNOUNCEMENT “ENOPARIN” OBTAINS APPROVAL FROM ARGENTINA
2025.02.18
VOLUNTARY ANNOUNCEMENT H1710 INJECTION RECEIVED THE NOTICE OF APPROVAL FOR CLINI...
2025.02.14
VOLUNTARY ANNOUNCEMENT OBTAINING THE GMP CERTIFICATE FROM EMA
2025.01.24
POSITIVE PROFIT ALERT ANNOUNCEMENT FOR THE ESTIMATED 2024 ANNUAL RESULTS
2025.01.02
VOLUNTARY ANNOUNCEMENT ENTERING INTO DISTRIBUTION AGREEMENT WITH YONGTAI PHARMAC...
2024.10.30
2024 THIRD QUARTERLY REPORT
第一页
上一页
1
2
3
4
5
下一页
最后一页
